Outcome of Hodgkin's lymphoma and aggressive non-Hodgkin lymphoma patients refractory to salvage chemotherapy

被引：0
|
作者：
Castagna, L. [1 ]
Bramanti, S. [1 ]
Balzarotti, M. [1 ]
Giordano, L. [1 ]
Michieli, M. [2 ]
Anastasia, A. [1 ]
Magagnoli, M. [1 ]
Sarina, B. [1 ]
Todisco, E. [1 ]
Mazza, R. [1 ]
Nozza, A. [1 ]
Ibatici, A. [1 ]
Santoro, A. [1 ]
机构：
[1] Ist Clin Humanitas, Rozzano, Italy
[2] Ctr Riferimento Oncol, I-33081 Aviano, Italy
来源：
BONE MARROW TRANSPLANTATION | 2011年 / 46卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S249 / S249
页数：1
相关论文
共 50 条
  • [1] FLUDAP: Salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphoma
    Child, JA
    Johnson, SA
    Rule, S
    Smith, GM
    Morgan, GJ
    Johnson, PWM
    Prentice, AG
    Tollerfield, SM
    Wareham, E
    [J]. LEUKEMIA & LYMPHOMA, 2000, 37 (3-4) : 309 - 317
  • [2] Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma
    Stamatoullas, A
    Fruchart, C
    Bastit, D
    Boulet, D
    Monconduit, M
    Piguet, H
    Tilly, H
    [J]. CANCER, 1996, 77 (11) : 2302 - 2307
  • [3] Gemcitabine and vinorelbine chemotherapy for refractory or relapsing aggressive non-Hodgkin lymphoma
    Sivam, Vanessa
    Cook, Lucy
    Hughes, George
    Karadimitris, Anasatasios
    Marks, Alexandra J.
    Matthey, Francis
    Naresh, Kikkeri N.
    Szydlo, Richard M.
    Yarranton, Helen
    Kanfer, Edward J.
    Macdonald, Donald H.
    [J]. HEMATOLOGICAL ONCOLOGY, 2012, 30 (04) : 214 - 215
  • [4] Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma
    Yang, Shih-Hung
    Lin, Zhong-Zhe
    Kuo, Sung-Hsin
    Cheng, Ann-Lii
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (07) : 457 - 459
  • [5] Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphoma
    Cortelazzo, S
    Rambaldi, A
    Rossi, A
    Oldani, E
    Ghielmin, M
    Benedetti, F
    Tarella, C
    Zaglio, F
    Vitolo, U
    Di Nicola, M
    Pogliani, E
    Cavalli, F
    Gianni, AM
    Barbui, T
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (02) : 333 - 341
  • [6] Efficacy of Gemcitabine as Salvage Therapy for Relapsed and Refractory Aggressive Non-Hodgkin Lymphoma
    Zlotnick, Maya
    Avigdor, Abraham
    Ribakovsky, Elena
    Nagler, Arnon
    Kedmi, Meirav
    [J]. ACTA HAEMATOLOGICA, 2019, 141 (02) : 84 - 90
  • [7] Salvage Chemotherapy with R-DHAP in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma
    Schirmbeck, Nadine G. D.
    Mey, Ulrich J. M.
    Olivieri, Attilio
    Ko, Yon-Dschun
    Kaiser, Ulrich
    Flieger, Dimitri
    Witzens-Harig, Mathias
    Schmidt-Wolf, Ingo G. H.
    [J]. CANCER INVESTIGATION, 2016, 34 (08) : 361 - 372
  • [8] Ligustrazine as a salvage agent for patients with relapsed or refractory non-Hodgkin's lymphoma
    [J]. 中华医学杂志(英文版), 2010, (22) : 3206 - 3211
  • [9] Ligustrazine as a salvage agent for patients with relapsed or refractory non-Hodgkin's lymphoma
    Yang Xi-gui
    Jiang Chao
    [J]. CHINESE MEDICAL JOURNAL, 2010, 123 (22) : 3206 - 3211
  • [10] Dexa-BEAM as salvage therapy in patients with primary refractory aggressive Non-Hodgkin lymphoma
    Atta, Johannes
    Chow, B-Ai U.
    Weidmann, Eckhart
    Mitrou, Paris S.
    Hoelzer, Dieter
    Martin, Hans
    [J]. LEUKEMIA & LYMPHOMA, 2007, 48 (02) : 349 - 356
12345